Home  »  Technologies   »  The Current Price For Doximity Inc. (NYSE: DOCS): ...

The Current Price For Doximity Inc. (NYSE: DOCS): And Is It Worth Investing In?

During the recent session, Doximity Inc. (NYSE:DOCS)’s traded shares were 3.41 million. At the last check today, the stock’s price was $37.49, reflecting an intraday loss of -7.00% or -$2.82. The 52-week high for the DOCS share is $107.79, that puts it down -187.52 from that peak though still a striking 27.82% gain since the share price plummeted to a 52-week low of $27.06. The company’s market capitalization is $7.63B, and the average intraday trading volume over the past 10 days was 1.73 million shares, and the average trade volume was 2.49 million shares over the past three months.

Doximity Inc. (NYSE:DOCS) trade information

Doximity Inc. (DOCS) registered a -7.00% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -7.00% in intraday trading to $37.49 this Thursday, 08/04/22, hitting a weekly high. The stock’s 5-day price performance is -3.15%, and it has moved by 4.92% in 30 days. Based on these gigs, the overall price performance for the year is -28.72%. The short interest in Doximity Inc. (NYSE:DOCS) is 18.3 million shares and it means that shorts have 8.81 day(s) to cover.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.

Sponsored

The consensus price target of analysts on Wall Street is $48.15, which implies an increase of 22.14% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $35.00 and $67.00 respectively. As a result, DOCS is trading at a discount of -78.71% off the target high and 6.64% off the low.

Doximity Inc. (DOCS) estimates and forecasts

Statistics show that Doximity Inc. has underperformed its competitors in share price, compared to the industry in which it operates. Doximity Inc. (DOCS) shares have gone down -13.44% during the last six months, with a year-to-date growth rate less than the industry average at -12.20% against 0.40. Yet analysts are ramping up their growth forecast for the fiscal year 2022. Revenue is predicted to shrink -9.10% this quarter and then drop -21.10% in the quarter after that. In the rating firms’ projections, revenue will increase 32.50% compared to the previous financial year.

Revenue for the current quarter is expected to be $89.3 million as predicted by 11 analyst(s). Meanwhile, a consensus of 11 analyst(s) estimates revenue growth to $105.26 million by the end of Sep 2022.

While earnings are projected to return 476.70% in 2022, the next five years will return 6.15% per annum.

DOCS Dividends

Doximity Inc. is due to release its next quarterly earnings on November 09. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.

Doximity Inc. (NYSE:DOCS)’s Major holders

Doximity Inc. insiders own 2.28% of total outstanding shares while institutional holders control 78.59%, with the float percentage being 80.43%. Price (T.Rowe) Associates Inc is the largest shareholder of the company, while 287 institutions own stock in it. As of Mar 30, 2022, the company held over 12.67 million shares (or 11.47% of all shares), a total value of $660.05 million in shares.

The next largest institutional holding, with 9.23 million shares, is of Morgan Stanley’s that is approximately 8.35% of outstanding shares. At the market price on Mar 30, 2022, these shares were valued at $480.67 million.

Also, the Mutual Funds coming in first place with the largest holdings of Doximity Inc. (DOCS) shares are Price (T.Rowe) New Horizons Fund and Vanguard Total Stock Market Index Fund. Data provided on Mar 30, 2022 indicates that Price (T.Rowe) New Horizons Fund owns about 2.93 million shares. This amounts to just over 2.65 percent of the company’s overall shares, with a $152.5 million market value. The same data shows that the other fund manager holds slightly less at 2.43 million, or about 2.20% of the stock, which is worth about $126.81 million.

Leave a Comment

Your email address will not be published.

On Key

Related Posts

[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]